Advertisement
Screener

BioLineRx Ltd. (BLRX) Form 20-F: Annual report of foreign private issuer

BioLineRx Ltd. Form 20-F: Annual report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-03-23: Form 20-F; Period of report 2025-12-31; Description 20-F; Document zk2634707.htm.
  • 2025-03-31: Form 20-F; Period of report 2024-12-31; Description 20-F; Document zk2532907.htm.
  • 2024-03-26: Form 20-F; Period of report 2023-12-31; Description 20-F; Document zk2431178.htm.
  • 2023-03-22: Form 20-F; Period of report 2022-12-31; Description 20-F; Document zk2329404.htm.
FiledFormPeriod of reportDescriptionDocument
2026-03-2320-F2025-12-3120-Fzk2634707.htm
2025-03-3120-F2024-12-3120-Fzk2532907.htm
2024-03-2620-F2023-12-3120-Fzk2431178.htm
2023-03-2220-F2022-12-3120-Fzk2329404.htm
2022-03-1620-F2021-12-3120-Fzk2227464.htm
2021-02-2320-F2020-12-3120-Fzk2125609.htm
2020-03-1220-F2019-12-3120-Fzk2024121.htm
2019-03-2820-F2018-12-3120-Fzk1922849.htm
2018-03-0620-F2017-12-3120-Fzk1821295.htm
2017-03-2320-F2016-12-3120-Fzk1719666.htm
2016-03-1020-F2015-12-3120-Fzk1618165.htm
2015-03-2320-F2014-12-3120-Fzk1516444.htm
2014-03-1720-F2013-12-3120-Fzk1414565.htm
2013-03-1220-F2012-12-3120-Fzk1312709.htm
2012-03-2220-F2011-12-3120-Fzk1211168.htm